Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 6, keine Gesamtzahl für „moderate“
Suchtreffer
Begriffe & Kennungen
Comtess · 4.8 · Usually the adverse reactions caused by entacapone are mild to moderate. In clinical studies the most common a
Eintrag öffnenConbriza · 4.8 · The majority of adverse reactions occurring during the clinical trials were mild to moderate in severity and d
Eintrag öffnenCopalia · 4.5 · Caution required with concomitant use CYP3A4 inhibitors Concomitant use of amlodipine with strong or moderate
Eintrag öffnenCorlentor · 4.5 · Moderate CYP3A4 inhibitors
Eintrag öffnenCorlentor · 4.5 · Moderate CYP3A4 inhibitors Specific interaction studies in healthy volunteers and patients have shown that the
Eintrag öffnenCorlentor · 4.5 · The concomitant use of ivabradine with other moderate CYP3A4 inhibitors (e.g. fluconazole) may be considered a
Eintrag öffnenCotellic · 4.5 · Caution should be exercised if cobimetinib is co-administered with moderate CYP3A inhibitors. Moderate CYP3A i
Eintrag öffnenCotellic · 4.5 · In vitro, cobimetinib is a moderate inhibitor of BCRP (Breast Cancer Resistance Protein). No clinical DDI stud
Eintrag öffnenCotellic · 4.5 · Moderate CYP3A inhibitors (see section 4.4.)
Eintrag öffnenCresemba · 4.5 · (CYP3A4/5 induction) Efavirenz Not studied. The concomitant administration (CYP3A4/5 moderate inducer Efaviren
Eintrag öffnenCresemba · 4.5 · (CYP3A4/5 induction) Efavirenz Not studied. The concomitant administration (CYP3A4/5 moderate inducer Efaviren
Eintrag öffnenCresemba · 4.5 · (CYP3A4/5 induction) Etravirine Not studied. The concomitant administration (moderate CYP3A4/5 inducer) Isavuc
Eintrag öffnenCresemba · 4.5 · (CYP3A4/5 induction) Etravirine Not studied. The concomitant administration (moderate CYP3A4/5 inducer) Isavuc
Eintrag öffnenCresemba · 4.5 · (CYP3A4/5 induction) Nafcillin Not studied. The concomitant administration (moderate CY3A4/5 inducer) Isavucon
Eintrag öffnenCresemba · 4.5 · (CYP3A4/5 induction) Nafcillin Not studied. The concomitant administration (moderate CY3A4/5 inducer) Isavucon
Eintrag öffnenCresemba · 4.5 · Isavuconazole is a moderate inhibitor of CYP3A4/5; co-administration of isavuconazole with medicinal products
Eintrag öffnenCresemba · 4.5 · Isavuconazole is a moderate inhibitor of CYP3A4/5; co-administration of isavuconazole with medicinal products
Eintrag öffnenCresemba · 4.5 · No dose adjustment is warranted for moderate to mild CYP3A4/5 inhibitors.
Eintrag öffnenCresemba · 4.5 · No dose adjustment is warranted for moderate to mild CYP3A4/5 inhibitors.
Eintrag öffnenCrysvita · 4.8 · Adult patients with XLH or TIO: Hypersensitivity reactions were mild or moderate in severity. In XLH patients,
Eintrag öffnen